Summary
This integrative genomics study of 190 adipocyte samples reveals that DNA methylation variations are causally implicated in human obesity and its metabolic complications. By combining epigenome-wide association, transcriptomics, and Mendelian Randomisation with functional validation in adipocytes, the authors identify 864 obesity-associated methylation loci and connect them to altered expression of over 500 genes and specific regulatory mechanisms. The findings establish DNA methylation as a causal determinant of adipocyte dysfunction in obesity rather than merely a correlate.
UK applicability
These findings on epigenetic mechanisms of obesity may inform UK public health strategies and clinical intervention targeting, though the study is cell-culture and observational rather than a dietary intervention. The identification of methylation-driven adipocyte dysfunction could support precision medicine approaches in UK obesity management and metabolic disease prevention.
Key measures
DNA methylation patterns at 864 total loci (691 subcutaneous, 173 visceral); association P-values (P < 1 × 10-7); transcriptomic changes at >500 genes; causal effects inferred at 59 loci via Mendelian Randomisation; functional metabolic effects measured via CRISPR-activation and gene silencing
Outcomes reported
The study identified extensive DNA methylation changes associated with obesity across 691 loci in subcutaneous and 173 loci in visceral adipocytes, and connected these methylation variations to transcriptomic changes in over 500 target genes. Using Mendelian Randomisation and functional validation (CRISPR-activation and gene silencing), the researchers inferred causal effects of methylation on obesity and obesity-induced metabolic disturbances at 59 independent loci.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.